glp 1 and gip dual agonist Targeting GLP-1, & GCG in Obesity Type 2 Diabetes Research Frontiers | Clinical perspectives on

19 DPP4 inhibitors have gained recognition as oral anti-diabetic medications for the treatment of type 2 diabetes

A recent study unveiled at the ACR Convergence 2025 suggests that certain medications originally developed for diabetes and weight-loss treatment may also help reduce flare-ups in Rheumatoid Arthritis (RA)

Individual results vary based on factors like starting weight, lifestyle changes, and medical conditions

If you use fiber supplements, start small

2018;36(2) doi: 10.1111/1755-5922.12317

For individuals taking GLP-1 receptor agonist medications, as of 2025, no controlled human studies assessing allulose with GLP-1 receptor agonists have been identified